Did you know that we could be undertreating patients with psoriasis?

Credit available for this activity expires: 6/24/2023

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976067?src=mkm_podcast_addon_976067

International expert faculty discuss how sodium-glucose cotransporter-2 (SGLT2) inhibitors have changed the management of patients with heart failure (HF). Credit available for this activity expires: [06/24/23]

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/976002?src=mkm_podcast_addon_976002

Can anything improve anti-vascular epithelial growth factor (anti-VEGF) control of exudation in retinal disease? Learn how targeting the angiopoietin pathway may help.

Credit available for this activity expires: 6/23/2023

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975535?src=mkm_podcast_addon_975535

With incidence of food-induced anaphylaxis on the increase, are you up to date on how best to diagnose and manage patients with food allergies?

Credit available for this activity expires: 6/21/2023

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975719?src=mkm_podcast_addon_975719

Do you know the best imaging modalities to diagnose advanced age-related macular degeneration (AMD) and track its progress? Learn how to assess patients and how to discuss with them what the future may hold.

Credit available for this activity expires: 6/17/2023

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975758?src=mkm_podcast_addon_975758

Are you aware that there are now targeted therapies available for patients harboring exon 20 insertions, the third most common type of EGFR mutation in non-small cell lung cancer (NSCLC)?

Credit available for this activity expires: 6/20/2023

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975726?src=mkm_podcast_addon_975726

Patients with extensive-stage small cell lung cancer (ES-SCLC) have a 10-month survival of 10 months following standard frontline chemotherapy. Join the experts in discussing immune checkpoint inhibitors (ICIs) in patients with SCLC.

Credit available for this activity expires: 6/15/2023

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975532?src=mkm_podcast_addon_975532

Do you know how to safely manage treatment-related adverse events (TRAEs) associated with human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugates (ADCs)?

Credit available for this activity expires: 6/14/2023

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975383?src=mkm_podcast_addon_975383

What do the latest guidelines say about HF management? Drs Butler, Bozkurt, and McDonagh discuss.

Credit available for this activity expires: 6/13/2023

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975310?src=mkm_podcast_addon_975310

Do you know how and when to screen for depression in people with epilepsy, and when to manage depression and when to refer?

Credit available for this activity expires: 6/10/2023

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/975275?src=mkm_podcast_addon_975275